Dr. Maria-Domenica Cappellini
- Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico
via Francesco Sforza, 35
Born in Milan at June, 1949. Graduated in Medicine, at Milan in 1974. Specialized in Gastroenterology in 1978. Specialized in Hematology in 1981. Stage at the Pasteur Institut in Paris in 1975.
Stage at Instituut vor Anthropogenetica “Dept of Human Genetics” University of Leiden in 1976. From September 1981 to December 1982 Research Fellow at MRC, Molecular Hematology Unit, John Radcliffe Hospital, Oxford University.
Visiting Scientist of the same Unit for short period in 1983, 1984, 1985, 1987 for cooperative project. Associate Professor and since March 2002 full Professor of Internal Medicine at the University of Milan. Member of Italian Society of Hematology.
Member of Italian Society of Internal Medicine. Member of the Editorial Board of Haematologica. She performed researches on hereditary disorders of Red Blood Cells with particular interest for Thalassemia, RBC enzyme deficiency and Porphyrias.
She developed long term erythroid tissue culture techniques to study the hemoglobin switching and the induction of HbF by different compounds. She published more than 100 peer reviewed papers, invited speaker to several national and international meetings.
Pulmonary dysfunction in thalassaemia major: is there any relationship with body iron stores? Guidotti F, Piatti G, Marcon A, Cassinerio E, Giuditta M, Roghi A, Fasano V, Consonni D, Cappellini MD
Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemia. Cappellini MD, Porter JB, Musallam KM, Kattamis A, Viprakasit V, Galanello R, Taher AT. Eur J Intern Med. 2016 Mar;28:91-6. doi: 10.1016/j.ejim.2
Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study. Taher AT, Cappellini MD, Aydinok Y, Porter JB, Karakas Z, Viprakasit V, Siritanaratkul N, Kattamis A, Wang C, Zh
Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment. Porter JB, El-Alfy M, Viprakasit V, Giraudier S, Chan LL, Lai Y, El-Ali
Management of non-transfusion-dependent thalassemia: a practical guide. Taher AT, Cappellini MD. Drugs. 2014 Oct;74(15):1719-29. doi: 10.1007/s40265-014-0299-0. Review. PMID: 25255924
Dr. Maria-Domenica Cappellini is a partner of ENERCA